1. Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma
   Rikiya Taoka et al, 2022, Urologic Oncology: Seminars and Original Investigations CrossRef
2. Long‐term efficacy and predictive correlates of response to nivolumab in Japanese patients with esophageal cancer
   Ken Kato et al, 2020, Cancer Science CrossRef
3. Calcium Channel Blocker Nifedipine Suppresses Colorectal Cancer Progression and Immune Escape by Preventing NFAT2 Nuclear Translocation
   Ling Wu et al, 2020, Cell Reports CrossRef
4. Preliminary Exploration of a New Therapy for Interstitial Cystitis/Bladder Pain Syndrome: Botulinum Toxin A Combined with Sapylin
   Wenshuang Li et al, 2022, Toxins CrossRef
5. Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
   Ekaterina Blinova et al, 2019, Cells CrossRef
6. Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy
   Ekaterina Blinova et al, 2020, Cancers CrossRef
7. Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular Invasive Bladder Urothelial Carcinoma
   Ekaterina Blinova et al, 2021, International Journal of Molecular Sciences CrossRef